Percutaneous left atrial appendage occlusion: the Munich consensus document on definitions, endpoints and data collection requirements for clinical studies

EuroIntervention 2016;12:103-111. DOI: 10.4244/EIJV12I1A18

Apostolos Tzikas
Apostolos Tzikas1*, MD, PhD; David R. Holmes Jr2, MD; Sameer Gafoor3, MD; Carlos E. Ruiz4, MD, PhD; Carina Blomström-Lundqvist5, MD, PhD; Hans-Christoph Diener6, MD; Riccardo Cappato7, MD; Saibal Kar8, MD; Randal J. Lee9, MD, PhD; Robert A. Byrne10, MB, BCh, PhD; Reda Ibrahim11, MD; Dhanunjaya Lakkireddy12, MD; Osama I. Soliman13, MD, PhD; Michael Näbauer14, MD; Steffen Schneider15, PhD; Johannes Brachman16, MD; Jeffrey L. Saver17, MD; Klaus Tiemann18, MD;
1. AHEPA University Hospital, Thessaloniki, Greece; 2. Mayo Clinic, Rochester, MN, USA; 3. CardioVascular Center Frankfurt, Frankfurt, Germany; 4. Hackensack UMC Heart and Vascular Hospital and The Joseph M. Sanzari Children’s Hospital, Hackensack, NJ, US

The increasing interest in left atrial appendage occlusion (LAAO) for ischaemic stroke prevention in atrial fibrillation (AF) fuels the need for more clinical data on the safety and effectiveness of this therapy. Besides an a

Sign in to read and download the full article

Forgot your password?

No account yet?
Sign up for free!

Create my pcr account

Join us for free and access thousands of articles from EuroIntervention, as well as presentations, videos, cases from

Interventions for strokeLAA closure
Read next article
Cardiac computed tomography and magnetic resonance imaging: complementary or competing?

Latest news